You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Cell-based cancer diagnostics company Celcuity today said in a regulatory document that it intends to offer 2 million shares of its common stock at between $8 and $10 per share as part of its initial public offering.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.